I. Farrance

发表

Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor.

T. Ma, A. Tsai, Xuegang Yuan, 2018, Biochemical engineering journal.

Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload

Lai-Hua Xie, M. Abdellatif, D. Lim, 2019, Circulation research.

Basal and α1-adrenergic-induced activity of minimal rat βMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites

P. Simpson, I. Farrance, B. McLean, 2003 .

Cell-specific expression of SERCA, the exogenous Ca2+ transport ATPase, in cardiac myocytes.

I. Farrance, G. Inesi, Hailun Ma, 2004, American journal of physiology. Cell physiology.

Comparison of SERCA 1 and SERCA 2 a expressed in COS-1 cells and cardiac myocytes

I. Farrance, L. Zhong, G. Inesi, 1999 .

Tight Control of Exogenous SERCA Expression Is Required to Obtain Acceleration of Calcium Transients With Minimal Cytotoxic Effects in Cardiac Myocytes

I. Farrance, G. Inesi, Hailun Ma, 2001, Circulation research.

endothelial function in pre and stage I hypertensives

S. Brant, H. Jo, Joon-Young Park, 2007 .

Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites.

P. Simpson, I. Farrance, B. McLean, 2003, Journal of Molecular and Cellular Cardiology.

Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes.

I. Farrance, L. Zhong, G. Inesi, 1999, American journal of physiology. Heart and circulatory physiology.

Endotoxin stress-response in cardiomyocytes: NF-κB activation and tumor necrosis factor-α expression

I. Singh, A. Cross, T. Rogers, 2002 .

M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1.

I. Farrance, J. Mar, C. Ordahl, 1992, The Journal of biological chemistry.

Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription.

I. Farrance, J. Mar, C. Ordahl, 1994, The Journal of biological chemistry.

Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation.

A. Wildeman, I. Farrance, P. Zuzarte, 2000, Biochimica et biophysica acta.

DTEF-1, a Novel Member of the Transcription Enhancer Factor-1 (TEF-1) Multigene Family (*)

A. Azakie, I. Farrance, C. Ordahl, 1996, The Journal of Biological Chemistry.

The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.

M. Yaffe, I. Farrance, W. M. Mahoney, 2005, The Biochemical journal.

Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter.

P. Simpson, K. Kariya, I. Farrance, 1993, The Journal of biological chemistry.

Mouse DTEF-1 (ETFR-1, TEF-5) Is a Transcriptional Activator in α1-Adrenergic Agonist-stimulated Cardiac Myocytes*

A. Stewart, I. Farrance, Tomoji Maeda, 2002, The Journal of Biological Chemistry.

Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression.

I. Singh, A. Cross, T. Rogers, 2002, American journal of physiology. Heart and circulatory physiology.

Prolactin-deficient GH3B3 cells are defective in the utilization of the endogenous prolactin promoter yet are fully competent to initiate transcription from a transfected prolactin promoter.

R. Ivarie, I. Farrance, J. Morris, 1991, DNA and cell biology.

Ethylation of poly(dC-dG).poly(dC-dG) by ethyl methanesulfonate stimulates the activity of mammalian DNA methyltransferase in vitro.

R. Ivarie, I. Farrance, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Improved chemistry for oligodeoxyribonucleotide synthesis substantially improves restriction enzyme cleavage of a synthetic 35mer.

R. Ivarie, I. Farrance, J. Eadie, 1989, Nucleic acids research.

Synthesis of N7-ethyldeoxyguanosine 5'-triphosphate and placement of N7-ethylguanine in a specific site in a synthetic oligodeoxyribonucleotide.

R. Ivarie, I. Farrance, 1989, Analytical biochemistry.

The Role of Transcription Enhancer Factor-1 (TEF-1) Related Proteins in the Formation of M-CAT Binding Complexes in Muscle and Non-muscle Tissues (*)

I. Farrance, C. Ordahl, Charles P. Ordahl, 1996, The Journal of Biological Chemistry.

NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives.

S. Brant, H. Jo, Joon-Young Park, 2007, American journal of physiology. Heart and circulatory physiology.

Flanking sequences modulate the cell specificity of M-CAT elements

I. Farrance, C. Ordahl, S. Larkin, 1996, Molecular and cellular biology.

High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.

C. Iacobuzio-Donahue, S. Kern, I. Farrance, 2007, Cancer research.

Intermolecular interactions in the mechanism of skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase (SERCA1): evidence for a triprotomer.

David D. Thomas, J. Froehlich, I. Farrance, 2008, Biochemistry.